The Snyder Center achieves significant pain reduction with 7 in 10 patients. One of the reasons for this remarkable success is the intensive, methodical attention we give every case.
We consider our feedback-based methodology to be as important as our proprietary formulas and patented transdermal gel. In fact, our technique benefits from more than a decade of honing.
By devoting more time and resources to patient follow-up than even the most diligent physician might be able to, we can fine-tune treatment to individual needs.
We also communicate continually with the patient's physician throughout the evaluation and treatment process.
After our initial consultation with referring physician, we begin with a basic formula as indicated by the patient's condition. The formula is then adjusted based on the patient's response.
There is no charge during the evaluation phase — and no cost for treatment until we have determined that it brings results.
Throughout the treatment phase, we conduct a regular schedule of patient interviews. Our proprietary interview techniques facilitate further tuning, until optimal results are achieved.
This intensive process itself gives us further insight into the chemistry and physiology of pain. Over the years, the valuable feedback, along with study, testing and observation, have led us to offer a new formulas and techniques designed for even more effective treatment.
HOW WE APPROACH PAIN RELIEF... (read on)
HOW WE APPROACH PATIENTS... (read on)
With pain formulas created specifically for transdermal gel delivery, we focus treatment directly to the point of pain, avoiding the toxic systemic side effects of pills. But unlike creams and ointments, our patented transdermal technology enables active ingredients to penetrate deep into the tissues, where the medicine affects the pain instead of the bloodstream.
Our proprietary transdermal carrier is so revolutionary, we have been awarded a patent for the discovery. In fact, the unique properties of the carrier are so superior that we license our patented technology to large pharmaceutical firms to produce their prescription medicines.